IL-13 — Drug Target

All drugs that target IL-13 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

IL-13 inhibitor · IL-13 inhibitor monoclonal antibody

Phase 3 pipeline (2)

• Tralokinumab + TCS · LEO Pharma · IL-13 inhibitor · Dermatology
  Tralokinumab is an IL-13 inhibitor, and when combined with topical corticosteroids (TCS), it targets the underlying inflammatory pathways in atopic dermatitis.
• GSK1358820 · GlaxoSmithKline · IL-13 inhibitor monoclonal antibody · Immunology / Respiratory
  GSK1358820 is a monoclonal antibody that targets and inhibits IL-13, a key cytokine involved in type 2 inflammatory responses.

Phase 2 pipeline (1)

• AER 001 · Aerovance, Inc. · IL-13 inhibitor · Respiratory
  AER 001 is an investigational monoclonal antibody targeting IL-13.